Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
Open Access
- 5 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Colorectal cancer (CRC) is one of the most common malignancies and is a major cause of cancer-related deaths worldwide. Thus, there is a clinical need to improve early detection of CRC and personalize therapy for patients with this disease. In the era of precision oncology, liquid biopsy has emerged as a major approach to characterize the circulating tumor elements present in body fluids, including cell-free DNA and RNA, circulating tumor cells, and extracellular vesicles. This non-invasive tool has allowed the identification of relevant molecular alterations in CRC patients, including some indicating the disruption of epigenetic mechanisms. Epigenetic alterations found in solid and liquid biopsies have shown great utility as biomarkers for early detection, prognosis, monitoring, and evaluation of therapeutic response in CRC patients. Here, we summarize current knowledge of the most relevant epigenetic mechanisms associated with cancer development and progression, and the implications of their deregulation in cancer cells and liquid biopsy of CRC patients. In particular, we describe the methodologies used to analyze these epigenetic alterations in circulating tumor material, and we focus on the clinical utility of epigenetic marks in liquid biopsy as tumor biomarkers for CRC patients. We also discuss the great challenges and emerging opportunities of this field for the diagnosis and personalized management of CRC patients.Keywords
Funding Information
- Instituto de Salud Carlos III (FI19/00240, JR17/00016, PI18/00307)
- Axencia Galega de Innovación (IN853B 2018/03)
- Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia
This publication has 288 references indexed in Scilit:
- Combinatorial complexity in chromatin structure and function: revisiting the histone codeCurrent Opinion in Genetics & Development, 2012
- Detection of Hypermethylated Vimentin in Urine of Patients with Colorectal CancerThe Journal of Molecular Diagnostics, 2012
- Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancerBritish Journal of Cancer, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissueInternational Journal of Colorectal Disease, 2003
- The language of covalent histone modificationsNature, 2000